Gritstone bio Overview

  • Founded
  • 2015
Founded
  • Status
  • Public
  • Employees
  • 181
Employees
  • Stock Symbol
  • GRTS
Stock Symbol
  • Share Price
  • $10.76
  • (As of Wednesday Closing)

Gritstone bio General Information

Description

Gritstone Bio Inc is a United States-based biotechnology company. It is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, BiSAb, among others.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Stock Exchange
NAS
Primary Office
  • 5959 Horton Street
  • Suite 300
  • Emeryville, CA 94608
  • United States
+1 (510) 000-0000

Gritstone bio Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Gritstone bio Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.76 $10.30 $2.54 - $35.20 $662M 64.3M 1.07M -$1.61

Gritstone bio Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 274,864 141,876 192,790 559,594
Revenue 44,824 4,037 4,365 1,187
EBITDA (65,659) (99,373) (93,195) (61,623)
Net Income (70,435) (105,314) (94,433) (64,775)
Total Assets 224,224 221,567 184,389 189,558
Total Debt 22,347 25,099 23,490 10,490
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Gritstone bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Gritstone bio‘s full profile, request access.

Request a free trial

Gritstone bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Gritstone bio‘s full profile, request access.

Request a free trial

Gritstone bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Gritstone Bio Inc is a United States-based biotechnology company. It is engaged in developing personalized cancer immuno
Biotechnology
Emeryville, CA
181 As of 2021
00000
000000000 00000

00000000

um dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
0000000000000
Boston, MA
000 As of 0000
00000
00000000000 00000

00000000

e cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in cu
0000000000000
San Diego, CA
000 As of 0000
00000
000000000 - 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Gritstone bio Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ziopharm Oncology Formerly VC-backed Boston, MA 000 00000 00000000000 00000
00000000 000000000 Formerly VC-backed San Diego, CA 000 00000 000000000 - 00000
000000 00000000000 Formerly VC-backed Burlingame, CA 00 00000 000000 - 000 00000
00000000 Formerly VC-backed Mainz, Germany 0000 00.000 00000000 00.000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
You’re viewing 5 of 31 competitors. Get the full list »

Gritstone bio Patents

Gritstone bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3126707-A1 Multispecific binding proteins Pending 29-Jan-2019 0000000000
CA-3119752-A1 Alphavirus neoantigen vectors and interferon inhibitors Pending 07-Nov-2018 000000000
AU-2019374874-A1 Alphavirus neoantigen vectors and interferon inhibitors Pending 07-Nov-2018 000000000
EP-3877531-A1 Alphavirus neoantigen vectors and interferon inhibitors Pending 07-Nov-2018 000000000
EP-3836958-A1 Antigen-binding proteins targeting shared antigens Pending 17-Aug-2018 C07K16/2833

Gritstone bio Executive Team (16)

Name Title Board Seat Contact Info
Andrew Allen Ph.D Chief Executive Officer & Founder
Vassiliki Economides Chief Financial Officer, Finance & Executive Vice President
Erin Jones Chief Operating Officer
Roman Yelensky Ph.D Executive Vice President
Karin Jooss Ph.D Head of Research and Development
You’re viewing 5 of 16 executive team members. Get the full list »

Gritstone bio Board Members (10)

Name Representing Role Since
Elaine Jones Ph.D Self Chairman & Board Member 000 0000
Judith Li Lilly Asia Ventures Board Member 000 0000
Naiyer Rizvi MD Gritstone bio Board Member 000 0000
Richard Heyman Ph.D Self Board Member 000 0000
Shefali Agarwal MD Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Gritstone bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gritstone bio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Gritstone bio‘s full profile, request access.

Request a free trial